Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2
Dyslipidemia is considered as the most common risk factor for cardiovascular diseases, cerebrovascular diseases, and fatty liver disease. The available therapy aimed to decrease lipid profile and reduced long-term risk which do require lifelong therapy, hence adverse effects are suggestive Continue reading